Total Payments
$1,530
2020 Payments
$145.20
Companies
11
Transactions
101
Medicare Patients
1,824
Medicare Billing
$236,456
Payment Breakdown by Category
Food & Beverage$1,530 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,530 | 101 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $615.82 | 40 | $0 (2020) |
| Lilly USA, LLC | $254.14 | 12 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $168.61 | 12 | $0 (2018) |
| Amgen Inc. | $155.95 | 13 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $105.28 | 7 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $86.17 | 6 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $40.41 | 3 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.09 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $36.83 | 3 | $0 (2019) |
| PFIZER INC. | $15.90 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $145.20 | 4 | Lilly USA, LLC ($124.00) |
| 2019 | $325.28 | 12 | Novo Nordisk Inc ($299.63) |
| 2018 | $653.55 | 51 | Novo Nordisk Inc ($184.20) |
| 2017 | $406.09 | 34 | Novo Nordisk Inc ($110.79) |
All Payment Transactions
101 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diabetes | ||||||
| 02/19/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $100.00 | General |
| 02/19/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 02/19/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $6.00 | General |
| 12/11/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 10/08/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $123.82 | General |
| Category: Diabetes | ||||||
| 08/27/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 05/08/2019 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $68.54 | General |
| Category: Diabetes | ||||||
| 05/03/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 03/22/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.41 | General |
| 03/15/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Diabetes | ||||||
| 03/08/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/21/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Diabetes | ||||||
| 02/16/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Diabetes | ||||||
| 02/08/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: DIABETES | ||||||
| 01/25/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Diabetes | ||||||
| 12/21/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 12/04/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Diabetes | ||||||
| 11/07/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Diabetes | ||||||
| 10/16/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: Respiratory | ||||||
| 10/11/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Diabetes | ||||||
| 09/27/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Diabetes | ||||||
| 09/19/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Obesity | ||||||
| 09/18/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 436 | 480 | $195,114 | $50,135 |
| 2022 | 5 | 429 | 448 | $211,635 | $63,698 |
| 2021 | 8 | 416 | 500 | $194,692 | $52,914 |
| 2020 | 8 | 543 | 597 | $141,012 | $69,709 |
Total Patients
1,824
Total Services
2,025
Medicare Billing
$236,456
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 210 | 219 | $113,715 | $29,285 | 25.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 79 | 81 | $28,065 | $8,046 | 28.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 89 | $23,632 | $5,539 | 23.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 72 | 76 | $20,523 | $4,862 | 23.7% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 15 | 15 | $9,179 | $2,403 | 26.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 247 | 264 | $132,517 | $40,790 | 30.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 99 | 101 | $48,027 | $14,076 | 29.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 36 | $13,219 | $3,524 | 26.7% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 35 | 35 | $11,740 | $3,269 | 27.8% |
| 99236 | Hospital observation or inpatient care admitted and discharged on the same day for high severity problem, typically 55 minutes | Facility | 2022 | 12 | 12 | $6,132 | $2,039 | 33.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 160 | 166 | $83,949 | $27,031 | 32.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 64 | 65 | $25,294 | $6,911 | 27.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 117 | $32,938 | $6,486 | 19.7% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 46 | 46 | $16,386 | $4,726 | 28.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 45 | 50 | $14,186 | $2,791 | 19.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 29 | $11,238 | $2,335 | 20.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 14 | 14 | $6,983 | $1,908 | 27.3% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 13 | 13 | $3,718 | $724.75 | 19.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 247 | 255 | $78,146 | $37,839 | 48.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 50 | 51 | $20,910 | $8,453 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 67 | 67 | $8,710 | $7,103 | 81.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 37 | 39 | $12,443 | $5,414 | 43.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 81 | $9,720 | $5,008 | 51.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 68 | $5,304 | $2,836 | 53.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 20 | 20 | $2,900 | $1,605 | 55.3% |
About Dr. Brenda Nyamogo, MD
Dr. Brenda Nyamogo, MD is a Internal Medicine healthcare provider based in North Conway, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2014. The National Provider Identifier (NPI) number assigned to this provider is 1912325176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brenda Nyamogo, MD has received a total of $1,530 in payments from pharmaceutical and medical device companies, with $145.20 received in 2020. These payments were reported across 101 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,530).
As a Medicare-enrolled provider, Nyamogo has provided services to 1,824 Medicare beneficiaries, totaling 2,025 services with total Medicare billing of $236,456. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location North Conway, NH
- Active Since 04/03/2014
- Last Updated 02/17/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1912325176
Products in Payments
- Ozempic (Drug) $172.44
- Victoza (Drug) $161.35
- Tresiba (Drug) $125.26
- Repatha (Biological) $110.45
- Saxenda (Drug) $75.82
- BEVESPI AEROSPHERE (Drug) $69.41
- Xultophy 100/3.6 (Drug) $68.54
- TRADJENTA (Drug) $65.82
- TOUJEO (Drug) $60.83
- STIOLTO (Drug) $60.11
- SYMBICORT (Drug) $50.39
- FARXIGA (Drug) $48.81
- Prolia (Biological) $45.50
- ELIQUIS (Drug) $40.41
- JANUVIA (Drug) $36.83
- HUMALOG (Drug) $32.91
- Trintellix (Drug) $30.42
- SOLIQUA (Drug) $29.70
- STIOLTO RESPIMAT (Drug) $26.06
- TRULICITY (Drug) $16.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in North Conway
Dr. Suzanne Abkowitz, Md, MD
Internal Medicine — Payments: $2,945
Internal Medicine $2,945
Dr. Jessica D'amico, Do, DO
Internal Medicine — Payments: $244.04
Internal Medicine $244.04
Chandrakumar Singarayer, M.d, M.D
Internal Medicine
Internal Medicine
Joseph Barefoot, M.d, M.D
Internal Medicine
Internal Medicine